Abiomed, Inc.ABMDNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank100
3Y CAGR+29.4%
5Y CAGR+39.5%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+29.4%/yr
vs +64.9%/yr prior
5Y CAGR
+39.5%/yr
Recent deceleration
Acceleration
-35.4pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
5.3x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2022$500.46M+102.7%
2021$246.94M-4.1%
2020$257.48M+11.6%
2019$230.77M+40.3%
2018$164.45M+73.5%
2017$94.79M+39.4%
2016$67.99M+117.6%
2015$31.24M+190.5%
2014$10.75M-44.2%
2013$19.27M-